Oxana Beskrovnaya, Chief Scientific Officer at Dyne Therapeutics, Inc. (DYN), sold 4,678 shares at $34.55 ($162K) on 2024-09-18, disclosed to the SEC on 2024-09-19.
Scheduled sale ($162k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.55 | 2,339 | $81K | 50.0% |
| 2 | $34.55 | 2,339 | $81K | 50.0% |
| Total | $34.55 avg | 4,678 | $162K | 100% |
| Filing → |
| DYN | SELL | 2025-02-25 | $36K | — | Filing → |
| DYN | SELL | 2024-12-11 | $131K | — | Filing → |
| DYN | SELL | 2024-11-18 | $161K | — | Filing → |